AJ Pharma Developing the World’s First Halal Vaccines
Highlights: AJ Vaccines, a Malaysian company that is part of the Al-Jomaih Group in Saudi Arabia, is focusing on developing non-animal derived vaccines. The company is currently developing the world’s first halal-certified meningococcal vaccine (MCV4), which began phase I in late 2016. This vaccine will be essential for all pilgrims traveling to Saudi Arabia. In addition, the company is also working on an animal source-free polio vaccine, which would be a significant contribution to the Islamic world. The Al-Jomaih Group is one of the top 10 conglomerates in Saudi Arabia, with a revenue of approximately $3 billion in the Kingdom of Saudi Arabia. The group focuses on investing in the healthcare and biotechnology sectors in the region, and their collaboration with AJ Vaccines demonstrates their commitment to developing innovative healthcare solutions.
Link to Original Article
https://www.salaamgateway.com/story/case-study-aj-pharma-developing-the-worlds-first-halal-vaccines